title: Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
authors.forename: J
authors.initials: J
authors.lastname: Hirsh
authors.forename: R
authors.initials: R
authors.lastname: Raschke
authors.forename: T E
authors.initials: TE
authors.lastname: Warkentin
authors.forename: J E
authors.initials: JE
authors.lastname: Dalen
authors.forename: D
authors.initials: D
authors.lastname: Deykin
authors.forename: L
authors.initials: L
authors.lastname: Poller
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D012449:Safety; D013921:Thrombocytopenia / Q000139:chemically induced
chemical_list: D000925:Anticoagulants; D006493:Heparin